Arrowhead Pharmaceuticals
ARWR
#2006
Rank
โ‚น912.06 B
Marketcap
โ‚น6,514
Share price
-1.18%
Change (1 day)
299.81%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -โ‚น104.69

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น112.88. In 2024 the company made an earnings per share (EPS) of -โ‚น451.50 a decrease over its 2023 EPS that were of -โ‚น172.73.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น104.69-76.81%
2024-โ‚น451.50161.39%
2023-โ‚น172.7317.36%
2022-โ‚น147.1819.85%
2021-โ‚น122.8161.9%
2020-โ‚น75.85-216.67%
2019โ‚น65.02-210.77%
2018-โ‚น58.7038.3%
2017-โ‚น42.44-64.93%
2016-โ‚น121.00-16.25%
2015-โ‚น144.4828%
2014-โ‚น112.88-3.85%
2013-โ‚น117.39-31.58%
2012-โ‚น171.57331.82%
2011-โ‚น39.73-51.11%
2010-โ‚น81.27-79.07%
2009-โ‚น388.29-37.68%
2008-โ‚น623.07-16.87%
2007-โ‚น749.4938.33%
2006-โ‚น541.80122.22%
2005-โ‚น243.8142.11%
2004-โ‚น171.57533.33%
2003-โ‚น27.09-99.08%
2002-โ‚น2,93225%
2001-โ‚น2,34533.33%
2000-โ‚น1,759-120%
1999โ‚น8,795-400%
1998-โ‚น2,932-81.48%
1997-โ‚น15,832

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น942.68-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-โ‚น728.72 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น215.82-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น8.13-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-โ‚น260.06 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA